EUVIMEDOpdag EUVIMED
Crossref

Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport

Irina P Fonareva iD, Elena V Svirshchevskaya iD, Elena V Mitroshina iD, Ekaterina A Marasanova, Maria V Vedunova, Elena A Zaburdaeva, Alexey Yu Fedorov iD, Ekaterina S Shchegravina iD

ChemMedChem · 2026-10-28 · 21 (20)

DOI: 10.1002/cmdc.70555 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-10-26. Written by Irina P Fonareva and 7 co-authors. Institution: Department of Organic Chemistry, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation. Major MEDLINE topics: Monocarboxylic Acid Transporters, Pyrazoles, Symporters, Lactic Acid. 53 references. Funded by: Russian Science Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Monocarboxylate transporter 1 (MCT1) represents an attractive therapeutic target as an important regulator of tumor metabolism. In this study, we developed a convenient synthetic approach to novel 5‐arylpyrazole derivatives as potential MCT1 inhibitors. Eleven new pyrazole derivatives ( 17a–k ) were prepared through a six‐step sequence in 5%–19% overall yields. Screening using 3‐bromopyruvate assays revealed that compound 17c, bearing a 3‐fluorophenyl substituent, significantly inhibited MCT1‐mediated transport at below its cytotoxic concentrations. The compound 17c induced dose‐ and time‐dependent accumulation of intracellular lactate in multiple cell lines, confirming its ability to interfere with MCT1‐driven metabolism. These results identify 5‐arylpyrazoles as a promising chemotype of MCT1 inhibitors, and highlight compound 17c as a potential lead for further optimizations in cancer metabolism‐targeted therapy.

Subjects

MeSH terms (MEDLINE)

Monocarboxylic Acid TransportersPyrazolesSymportersLactic AcidAntineoplastic AgentsMonocarboxylate Transport Protein 1HumansStructure-Activity RelationshipMolecular StructureCell Line, TumorDose-Response Relationship, DrugBiological Transport

Author keywords

MCT1 inhibitorsgliomapyrazole derivativestumor lactate metabolism

Substances

Monocarboxylic Acid TransportersPyrazolesMonocarboxylate Transport Protein 1SymportersLactic AcidAntineoplastic Agents

Authors and institutions

  • Department of Organic Chemistry, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation.
  • Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russian Federation.
  • Institute of biology and biomedicine, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation.

ORCID profiles: Irina P Fonareva, Elena V Svirshchevskaya, Elena V Mitroshina, Alexey Yu Fedorov, Ekaterina S Shchegravina

Funding

  • Russian Science Foundation

Cite

APA

Fonareva, I. P., Svirshchevskaya, E. V., Mitroshina, E. V., Marasanova, E. A., Vedunova, M. V., Zaburdaeva, E. A., Fedorov, A. Y., & Shchegravina, E. S. (2026). Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70555

Vancouver

Fonareva IP, Svirshchevskaya EV, Mitroshina EV, Marasanova EA, Vedunova MV, Zaburdaeva EA, et al. Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70555

BibTeX
@article{Fonareva2026,
  author = {Fonareva, Irina P and Svirshchevskaya, Elena V and Mitroshina, Elena V and Marasanova, Ekaterina A and Vedunova, Maria V and Zaburdaeva, Elena A and Fedorov, Alexey Yu and Shchegravina, Ekaterina S},
  title = {Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70555}
}
Start for free →